Trials / Completed
CompletedNCT02176343
Retrospective / Prospective Clinical Study of AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric Intraocular Lenses
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to characterize the safety and effectiveness of the ACRYSOF IQ ReSTOR +2.5 diopter (D) Multifocal Toric Intraocular Lens (IOL) in subjects at least 3 months and no more than 14 months after IOL implantation.
Detailed description
This is a retrospective and prospective clinical study comprised of a retrospective chart review for preoperative, surgical and early postoperative data, and a prospective postoperative visit conducted at least 3 months but not more than 14 months after IOL implantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric IOL | Multifocal IOL with extended secondary focal point and astigmatism correction implanted for long-term use over the lifetime of the cataract patient |
Timeline
- Start date
- 2014-07-21
- Primary completion
- 2014-08-22
- Completion
- 2014-08-22
- First posted
- 2014-06-27
- Last updated
- 2018-07-02
- Results posted
- 2017-06-29
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02176343. Inclusion in this directory is not an endorsement.